Remove Biobanking Remove Cardiology Remove Genomics Remove Trials
article thumbnail

HFpEF vs. HFrEF: How To Improve Heart Failure Drug Development

XTalks

Late-stage clinical trial failures are largely to blame for the lack of effective treatment options for patients with HFpEF, and poor five-year survival rates make this an area of great unmet need. New advances in heart failure genomics are helping to address this challenge. Heart failure affects about 6.2